Recruiting × Interventional × Head and Neck Neoplasms × Clear all Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body
Phase NA Recruiting
1,400 enrolled
Phase I Study of Preconditioning Radiation Therapy With IL-15 Transduced TGFBR2 KO CAR.TROP2-engineered Cord Blood-derived NK Cells in Patients With Advanced Head and Neck Cancer (RADIANCE-NK)
Phase 1 Recruiting
33 enrolled
Web-Based Program in Helping Patients With Head and Neck Cancer Adhere to Swallowing Exercises and Coping Strategies
Phase 2 Recruiting
300 enrolled
AHEAD-MERIT
Phase 2/3 Recruiting
350 enrolled
STOPOMP
Phase NA Recruiting
63 enrolled
Phase I/ II Trial Combining PD-1 Inhibition and Neoadjuvant Proton or Photon Radiation Therapy in Recurrent Head and Neck Squamous Cell Carcinoma
Phase 1/2 Recruiting
40 enrolled
A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY)
Phase 2 Recruiting
120 enrolled
Palliative Steroeotactic Body Radiotherapy vs Palliative Standard Radiotherapy in Patients With Advanced Head and Neck Cancer
Phase 3 Recruiting
196 enrolled
Eliminate
Phase 2/3 Recruiting
396 enrolled
Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
Phase 1 Recruiting
56 enrolled
ReRT
Phase NA Recruiting
1,800 enrolled
FIBROTHERME
Phase NA Recruiting
110 enrolled
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Phase 2 Recruiting
30 enrolled
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 Recruiting
310 enrolled
PRECISE
Phase NA Recruiting
30 enrolled
TRIDENT-1
Phase 1/2 Recruiting
500 enrolled 5 FDA
Topical Diclofenac for Prevention of Radiation-induced Dermatitis
Phase NA Recruiting
156 enrolled
DART-HN
Phase NA Recruiting
40 enrolled
Phase 2 Trial of Adaptive Radiotherapy Boost for HNSCC
Phase 2 Recruiting
35 enrolled
An Imaging Agent (Pafolacianine) for Identifying Lesions in Pediatric Patients With Primary or Metastatic Solid Tumors
Phase 3 Recruiting
20 enrolled
Development and Application of a Nurse-Led Preemptive Symptom Management Protocol for Head and Neck Cancer Patients Undergoing Radiation Therapy
Phase 3 Recruiting
170 enrolled
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
Phase 1 Recruiting
40 enrolled
PBM-LEF
Phase NA Recruiting
60 enrolled
LEAH
Phase NA Recruiting
5,909 enrolled
Pembrolizumab Plus Ultrasound-Induced Microbubble Cavitation in Head and Neck Cancer
Phase 1 Recruiting
6 enrolled
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)
Phase 3 Recruiting
500 enrolled
Topical Periplaneta Americana-Derived Meilian Fuxin Liquid for Radiation Dermatitis
Phase 2/3 Recruiting
60 enrolled
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC
Phase 1 Recruiting
110 enrolled
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Phase 2 Recruiting
32 enrolled
OZOMUC
Phase NA Recruiting
50 enrolled
FORTIFI-HN01
Phase 2/3 Recruiting
650 enrolled
APAORL2
Phase NA Recruiting
96 enrolled
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
233 enrolled
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
Phase NA Recruiting
111 enrolled
Feasibility Study of CBCT for IGRT in Cancer Patients
Phase NA Recruiting
50 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
Pilot Study of Management of Facial Paralysis in the Oncologic Patient: Nerve Transfer Techniques to Improve Facial Function and Quality of Life
Phase NA Recruiting
40 enrolled
Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer
Phase 2 Recruiting
224 enrolled
Digi-Coach
Phase NA Recruiting
138 enrolled
(NeoScorch HN)
Phase 2 Recruiting
75 enrolled
Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer
Phase 2 Recruiting
30 enrolled
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Phase NA Recruiting
860 enrolled
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients With Previously Treated Head and Neck Cancer
Phase 1 Recruiting
30 enrolled
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
Phase 1 Recruiting
150 enrolled
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
Phase 2 Recruiting
38 enrolled
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
Phase 2 Recruiting
268 enrolled
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
250 enrolled
TRADstat
Phase 2 Recruiting
48 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
Iparomlimab and Tuvonralimab Plus Hypofractionated Radiotherapy and Chemotherapy for HAHNSCC
Phase 2 Recruiting
27 enrolled